5-lipoxygenase inhibitors (Galileo)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-lipoxygenase inhibitors (Galileo)
Drug Alias Name5-LO inhibitors (Galileo)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenase
Therapy Area/IndicationsInflammationDiabetes MellitusCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGalileo Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalileo Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes MellitusCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A